AXQ Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,680
| Closed | -$320K | – | 416 |
|
|
2024
Q2 | $320K | Buy |
19,680
+2,901
| +17% | +$47.1K | 0.07% | 358 |
|
|
2024
Q1 | $310K | Buy |
16,779
+8,278
| +97% | +$153K | 0.07% | 422 |
|
|
2023
Q4 | $266K | Sell |
8,501
-11,050
| -57% | -$346K | 0.07% | 416 |
|
|
2023
Q3 | $407K | Buy |
+19,551
| New | +$407K | 0.14% | 242 |
|
|
2023
Q2 | – | Sell |
-12,339
| Closed | -$232K | – | 264 |
|
|
2023
Q1 | $232K | Buy |
+12,339
| New | +$232K | 0.09% | 372 |
|